Landscape of phase 1 clinical trials for minors with cancer in the United States.

Jaclynne H NaderDylan V NeelDavid S ShulmanClement MaFlorence BourgeoisSteven G DuBois

Published in: Pediatric blood & cancer (2020)

The paucity of clear temporal trends highlights the need for innovation in early drug development for young people. Our analysis serves as a benchmark against which to evaluate initiatives to improve pediatric cancer drug development.

Keyphrases

papillary thyroid
clinical trial
squamous cell
childhood cancer
lymph node metastasis
single cell
randomized controlled trial
quality improvement
young adults